Your browser doesn't support javascript.
loading
Rapid growth of primary uveal melanoma following intravitreal bevacizumab injection: a case report and review of the literature.
Ma, Jingyi; Roelofs, Kelsey A; Russell, Laurie; Weis, Ezekiel; Chen, Sylvia H.
Affiliation
  • Ma J; Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Roelofs KA; Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alberta, Canada.
  • Russell L; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
  • Weis E; Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alberta, Canada.
  • Chen SH; Department of Surgery, University of Calgary, Calgary, Alberta, Canada.
Digit J Ophthalmol ; 26(3): 27-30, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33867879

Full text: 1 Database: MEDLINE Main subject: Uveal Neoplasms / Glaucoma, Neovascular / Angiogenesis Inhibitors / Drug-Related Side Effects and Adverse Reactions / Bevacizumab / Melanoma Type of study: Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Uveal Neoplasms / Glaucoma, Neovascular / Angiogenesis Inhibitors / Drug-Related Side Effects and Adverse Reactions / Bevacizumab / Melanoma Type of study: Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Year: 2021 Type: Article